Cargando…
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis
Claudin-2 enhances breast cancer liver metastasis and promotes the development of colorectal cancers. The objective of our current study is to define the regulatory mechanisms controlling Claudin-2 expression in breast cancer cells. We evaluated the effect of several Src Family Kinase (SFK) inhibito...
Autores principales: | Tabariès, Sébastien, Annis, Matthew G., Hsu, Brian E., Tam, Christine E., Savage, Paul, Park, Morag, Siegel, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496232/ https://www.ncbi.nlm.nih.gov/pubmed/25823815 |
Ejemplares similares
-
Afadin cooperates with Claudin-2 to promote breast cancer metastasis
por: Tabariès, Sébastien, et al.
Publicado: (2019) -
Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases
por: Tabariès, Sébastien, et al.
Publicado: (2015) -
Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern
por: Tabariès, Sébastien, et al.
Publicado: (2021) -
p66ShcA functions as a contextual promoter of breast cancer metastasis
por: Lewis, Kyle, et al.
Publicado: (2020) -
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis
por: Peikert, Kevin, et al.
Publicado: (2021)